Ignite Creation Date:
2025-12-24 @ 5:08 PM
Ignite Modification Date:
2026-06-23 @ 3:23 PM
Study NCT ID:
NCT06319950
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-03-20
First Post:
2024-03-01
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
High-dose Furmonertinib Versus Osimertinib in Advanced EGFRm NSCLC Patients With Brain Metastases
Sponsor:
Taizhou Hospital
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Lung Cancer, Nonsmall Cell | View |